FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2311331156> ?p ?o ?g. }

• W2311331156 endingPage "1450" @default.
• W2311331156 startingPage "1442" @default.
• W2311331156 abstract "Oral direct-acting antivirals (DAAs) represent a major advance in hepatitis C virus (HCV) treatment. Along with recent updates in HCV screening policy and expansions in insurance coverage, treatment demand in the United States is changing rapidly. Our objective was to project the characteristics and number of people needing antiviral treatment and HCV-associated disease burden in the era of oral DAAs. We used a previously developed and validated Hepatitis C Disease Burden Simulation model (HEP-SIM). HEP-SIM simulated the actual clinical management of HCV from 2001 onward, which included antiviral treatment with pegylated interferon (Peg-IFN)-based therapies as well as the recent oral DAAs, risk-based and birth-cohort HCV screening, and the impact of the Affordable Care Act. We also simulated two hypothetical scenarios—no treatment and treatment with Peg-IFN-based therapies only. We estimated that in 2010, 2.5 (95% confidence interval [CI], 1.9-3.1) million noninstitutionalized people were viremic, which dropped to 1.9 (95% CI, 1.4-2.6) million in 2015, and projected to drop below 1 million by 2020. A total of 1.8 million HCV patients will receive HCV treatment from the launch of oral DAAs in 2014 until 2030. Based on current HCV management practices, it will take 4-6 years to treat the majority of patients aware of their disease. However, 560,000 patients would still remain unaware by 2020. Even in the oral DAA era, 320,000 patients will die, 157,000 will develop hepatocellular carcinoma, and 203,000 will develop decompensated cirrhosis in the next 35 years. Conclusions: HCV-associated disease burden will still remain substantial in the era of oral DAAs. Increasing HCV screening and treatment capacity is essential to further decreasing HCV burden in the United States. (Hepatology 2016;64:1442-1450)" @default.
• W2311331156 created "2016-06-24" @default.
• W2311331156 creator A5020069661 @default.
• W2311331156 creator A5021379796 @default.
• W2311331156 creator A5038177258 @default.
• W2311331156 creator A5040123651 @default.
• W2311331156 creator A5043740961 @default.
• W2311331156 creator A5055200350 @default.
• W2311331156 creator A5058147391 @default.
• W2311331156 creator A5080856261 @default.
• W2311331156 creator A5086965411 @default.
• W2311331156 date "2016-06-01" @default.
• W2311331156 modified "2023-10-18" @default.
• W2311331156 title "Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals" @default.
• W2311331156 cites W1497045310 @default.
• W2311331156 cites W1744400852 @default.
• W2311331156 cites W1980154502 @default.
• W2311331156 cites W1984413237 @default.
• W2311331156 cites W2008164329 @default.
• W2311331156 cites W2042063433 @default.
• W2311331156 cites W2058200448 @default.
• W2311331156 cites W2059496327 @default.
• W2311331156 cites W2065146174 @default.
• W2311331156 cites W2067273401 @default.
• W2311331156 cites W2070539863 @default.
• W2311331156 cites W2078799829 @default.
• W2311331156 cites W2081689022 @default.
• W2311331156 cites W2097068106 @default.
• W2311331156 cites W2111044696 @default.
• W2311331156 cites W2129802081 @default.
• W2311331156 cites W2143991614 @default.
• W2311331156 cites W2148341406 @default.
• W2311331156 cites W2148913966 @default.
• W2311331156 cites W2148959572 @default.
• W2311331156 cites W2161551077 @default.
• W2311331156 cites W2162317388 @default.
• W2311331156 cites W2162933087 @default.
• W2311331156 cites W2320154901 @default.
• W2311331156 cites W2325791202 @default.
• W2311331156 cites W2984566377 @default.
• W2311331156 doi "https://doi.org/10.1002/hep.28571" @default.
• W2311331156 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5035714" @default.
• W2311331156 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27015107" @default.
• W2311331156 hasPublicationYear "2016" @default.
• W2311331156 type Work @default.
• W2311331156 sameAs 2311331156 @default.
• W2311331156 citedByCount "124" @default.
• W2311331156 countsByYear W23113311562016 @default.
• W2311331156 countsByYear W23113311562017 @default.
• W2311331156 countsByYear W23113311562018 @default.
• W2311331156 countsByYear W23113311562019 @default.
• W2311331156 countsByYear W23113311562020 @default.
• W2311331156 countsByYear W23113311562021 @default.
• W2311331156 countsByYear W23113311562022 @default.
• W2311331156 countsByYear W23113311562023 @default.
• W2311331156 crossrefType "journal-article" @default.
• W2311331156 hasAuthorship W2311331156A5020069661 @default.
• W2311331156 hasAuthorship W2311331156A5021379796 @default.
• W2311331156 hasAuthorship W2311331156A5038177258 @default.
• W2311331156 hasAuthorship W2311331156A5040123651 @default.
• W2311331156 hasAuthorship W2311331156A5043740961 @default.
• W2311331156 hasAuthorship W2311331156A5055200350 @default.
• W2311331156 hasAuthorship W2311331156A5058147391 @default.
• W2311331156 hasAuthorship W2311331156A5080856261 @default.
• W2311331156 hasAuthorship W2311331156A5086965411 @default.
• W2311331156 hasBestOaLocation W23113311561 @default.
• W2311331156 hasConcept C126322002 @default.
• W2311331156 hasConcept C159047783 @default.
• W2311331156 hasConcept C177713679 @default.
• W2311331156 hasConcept C2522874641 @default.
• W2311331156 hasConcept C2776408679 @default.
• W2311331156 hasConcept C2776455275 @default.
• W2311331156 hasConcept C2776461080 @default.
• W2311331156 hasConcept C2777075537 @default.
• W2311331156 hasConcept C2778019345 @default.
• W2311331156 hasConcept C2779134260 @default.
• W2311331156 hasConcept C2780040827 @default.
• W2311331156 hasConcept C2780664029 @default.
• W2311331156 hasConcept C41260117 @default.
• W2311331156 hasConcept C71924100 @default.
• W2311331156 hasConcept C72563966 @default.
• W2311331156 hasConceptScore W2311331156C126322002 @default.
• W2311331156 hasConceptScore W2311331156C159047783 @default.
• W2311331156 hasConceptScore W2311331156C177713679 @default.
• W2311331156 hasConceptScore W2311331156C2522874641 @default.
• W2311331156 hasConceptScore W2311331156C2776408679 @default.
• W2311331156 hasConceptScore W2311331156C2776455275 @default.
• W2311331156 hasConceptScore W2311331156C2776461080 @default.
• W2311331156 hasConceptScore W2311331156C2777075537 @default.
• W2311331156 hasConceptScore W2311331156C2778019345 @default.
• W2311331156 hasConceptScore W2311331156C2779134260 @default.
• W2311331156 hasConceptScore W2311331156C2780040827 @default.
• W2311331156 hasConceptScore W2311331156C2780664029 @default.
• W2311331156 hasConceptScore W2311331156C41260117 @default.
• W2311331156 hasConceptScore W2311331156C71924100 @default.
• W2311331156 hasConceptScore W2311331156C72563966 @default.
• W2311331156 hasFunder F4320308573 @default.
• W2311331156 hasFunder F4320332161 @default.

• next